| The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man NL Sharma, CE Massie, A Ramos-Montoya, V Zecchini, HE Scott, ... Cancer cell 23 (1), 35-47, 2013 | 432 | 2013 |
| Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ... The lancet oncology 15 (13), 1521-1532, 2014 | 376 | 2014 |
| Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study H Ross-Adams, AD Lamb, MJ Dunning, S Halim, J Lindberg, CM Massie, ... EBioMedicine 2 (9), 1133-1144, 2015 | 282 | 2015 |
| Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data … NJ Sathianathen, A Omer, E Harriss, L Davies, V Kasivisvanathan, ... European urology 78 (3), 402-414, 2020 | 228 | 2020 |
| Meta-analysis showing the beneficial effect of alpha-blockers on ureteric stent discomfort AD Lamb, SL Vowler, R Johnston, N Dunn, OJ Wiseman Database of Abstracts of Reviews of Effects (DARE): Quality-assessed reviews …, 2011 | 183 | 2011 |
| Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer L Yang, D Roberts, M Takhar, N Erho, BAS Bibby, N Thiruthaneeswaran, ... EBioMedicine 31, 182-189, 2018 | 137 | 2018 |
| Gene regulatory mechanisms underpinning prostate cancer susceptibility T Whitington, P Gao, W Song, H Ross-Adams, AD Lamb, Y Yang, I Svezia, ... Nature genetics 48 (4), 387-397, 2016 | 121 | 2016 |
| Neuroendocrine differentiation of prostate cancer leads to PSMA suppression MK Bakht, I Derecichei, Y Li, RM Ferraiuolo, M Dunning, SW Oh, ... Endocrine-related cancer 26 (2), 131-146, 2019 | 116 | 2019 |
| Spatially resolved clonal copy number alterations in benign and malignant tissue A Erickson, M He, E Berglund, M Marklund, R Mirzazadeh, N Schultz, ... Nature 608 (7922), 360-367, 2022 | 100 | 2022 |
| Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype JLL Robinson, TE Hickey, AY Warren, SL Vowler, T Carroll, AD Lamb, ... Oncogene 33 (50), 5666-5674, 2014 | 93 | 2014 |
| “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now J Grummet, MA Gorin, R Popert, T O’Brien, AD Lamb, B Hadaschik, ... Prostate cancer and prostatic diseases 23 (1), 62-65, 2020 | 82 | 2020 |
| HES6 drives a critical AR transcriptional programme to induce castration‐resistant prostate cancer through activation of an E 2 F 1‐mediated cell cycle network A Ramos‐Montoya, AD Lamb, R Russell, T Carroll, S Jurmeister, ... EMBO molecular medicine 6 (5), 651-661, 2014 | 82 | 2014 |
| Recurrence after totally extraperitoneal laparoscopic repair: implications for operative technique and surgical training ADG Lamb, AJ Robson, SJ Nixon The Surgeon 4 (5), 299-307, 2006 | 72 | 2006 |
| The early effects of rapid androgen deprivation on human prostate cancer GL Shaw, H Whitaker, M Corcoran, MJ Dunning, H Luxton, J Kay, ... European urology 70 (2), 214-218, 2016 | 69 | 2016 |
| Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ... Nature communications 12 (1), 5307, 2021 | 67 | 2021 |
| Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model Y Philippou, HT Sjoberg, E Murphy, S Alyacoubi, KI Jones, ... British journal of cancer 123 (7), 1089-1100, 2020 | 61 | 2020 |
| Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer NJ Sathianathen, YA Philippou, GM Kuntz, BR Konety, S Gupta, AD Lamb, ... Cochrane Database of Systematic Reviews, 2018 | 55 | 2018 |
| Mortality among men with advanced prostate cancer excluded from the ProtecT trial TJ Johnston, GL Shaw, AD Lamb, D Parashar, D Greenberg, T Xiong, ... European urology 71 (3), 381-388, 2017 | 55 | 2017 |
| The transcriptional programme of the androgen receptor (AR) in prostate cancer AD Lamb, CE Massie, DE Neal BJU Int 113 (3), 358-366, 2014 | 54 | 2014 |
| Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target M Asim, CE Massie, F Orafidiya, N Pértega-Gomes, AY Warren, ... Journal of the National Cancer Institute 108 (5), djv371, 2016 | 52 | 2016 |
